Public
All

ST PHARM's Public Release

ST PHARM NewsST Pharm Enhances Stakeholder Communication with Release of First Sustainability ReportJun 24, 2025
ST PHARM NewsST Pharm Joins TIDES USA 2025, Ramping Up Efforts in North American RNA Therapeutics MarketMay 26, 2025
ST PHARM News[Notice] Completion of Patient Enrollment for Interim Analysis of Phase 2a Study of STP0404 (Pirmitegravir)May 21, 2025
ST PHARM News[Notice] Research on ST Pharm’s Next-Generation mRNA Vaccine Candidate Published in PLOS Neglected Tropical DiseasesMay 15, 2025
ST PHARM NewsST Pharm Showcases New CRISPR Therapeutic Platforms at CRISPR Medicines 2025Apr 9, 2025
ST PHARM NewsST PHARM Participates in DCAT Week 2025, Seeking Global PartnershipsMar 21, 2025
ST PHARM NewsThe SMARTCAP® patent was granted in JapanMar 18, 2025
ST PHARM NewsUSPTO grants patent to Vernagen's mRNA-Based RSV A/B VaccineMar 11, 2025
ST PHARM NewsST PHARM 'Basroparib' Combination Therapy Preclinical Result PublishedMar 5, 2025
ST PHARM News[Notice] ST Pharm Completes Trademark Registration for Proprietary mRNA Platform Core Technologies (SMARTCAP® & STLNP®)Mar 4, 2025
ST PHARM NewsST Pharm and Evonik Collaborate to Advance mRNA Therapeutics through PartnershipJan 10, 2025
ST PHARM NewsST Pharm to Present Basroparib (STP1002) at ESMO Congress 2024Sep 6, 2024
ST PHARM NewsST Pharm Banwol Campus Awarded EcoVadis 'Gold' MedalSep 6, 2024
1of5
HOMEPublicPR (Public Relations)News roomAll
© 2025 ST Pharm. All rights reserved.